A detailed history of Orion Portfolio Solutions, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 8,809 shares of VRTX stock, worth $3.97 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
8,809
Previous 9,519 7.46%
Holding current value
$3.97 Million
Previous $4.46 Million 8.18%
% of portfolio
0.04%
Previous 0.05%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$460.0 - $505.78 $326,600 - $359,103
-710 Reduced 7.46%
8,809 $4.1 Million
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $445,053 - $550,105
1,133 Added 13.51%
9,519 $4.46 Million
Q1 2024

May 09, 2024

SELL
$407.69 - $446.08 $661,680 - $723,987
-1,623 Reduced 16.22%
8,386 $3.51 Million
Q4 2023

Feb 09, 2024

SELL
$343.0 - $410.68 $166,355 - $199,179
-485 Reduced 4.62%
10,009 $4.07 Million
Q3 2023

Nov 01, 2023

SELL
$338.18 - $362.46 $354,412 - $379,858
-1,048 Reduced 9.08%
10,494 $3.65 Million
Q2 2023

Aug 17, 2023

BUY
$314.42 - $351.91 $1.12 Million - $1.26 Million
3,571 Added 44.8%
11,542 $4.06 Million
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $2.29 Million - $2.57 Million
7,292 Added 1073.93%
7,971 $2.81 Million
Q1 2023

Aug 30, 2023

SELL
$283.23 - $323.1 $187,498 - $213,892
-662 Reduced 5.74%
10,880 $3.43 Million
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $475,259 - $542,161
-1,678 Reduced 71.19%
679 $213,000
Q4 2022

Feb 08, 2023

BUY
$285.76 - $321.48 $123,448 - $138,879
432 Added 22.44%
2,357 $680,000
Q3 2022

Nov 09, 2022

BUY
$273.83 - $305.53 $82,696 - $92,270
302 Added 18.61%
1,925 $557,000
Q2 2022

Jul 14, 2022

SELL
$234.96 - $292.55 $45,112 - $56,169
-192 Reduced 10.58%
1,623 $457,000
Q1 2022

May 19, 2022

SELL
$221.42 - $260.97 $83,918 - $98,907
-379 Reduced 17.27%
1,815 $474,000
Q4 2021

Feb 09, 2022

BUY
$177.01 - $223.45 $3,540 - $4,469
20 Added 0.92%
2,194 $482,000
Q3 2021

Nov 10, 2021

BUY
$181.39 - $202.99 $394,341 - $441,300
2,174 New
2,174 $394,000
Q2 2021

Aug 05, 2021

SELL
$187.49 - $221.1 $182,052 - $214,688
-971 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$207.02 - $241.31 $78,046 - $90,973
-377 Reduced 27.97%
971 $209,000
Q4 2020

Feb 04, 2021

SELL
$207.01 - $276.09 $34,363 - $45,830
-166 Reduced 10.96%
1,348 $319,000
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $87,432 - $103,660
342 Added 29.18%
1,514 $412,000
Q2 2020

Aug 19, 2020

BUY
$225.48 - $295.8 $56,595 - $74,245
251 Added 27.25%
1,172 $340,000
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $22,374 - $27,754
112 Added 13.84%
921 $219,000
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $134,868 - $181,143
809 New
809 $177,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.